ArticleAnnals of surgical oncology2025
Resection of Primary Leiomyosarcoma of the Inferior Vena Cava and Reconstruction with a Cadaveric Homograft.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Refining the Contemporary Management of Primary Retroperitoneal Soft Tissue Sarcoma: Outcome Improvement Over Time at a Single Institution.Annals of surgical oncology · 2026Article
- Diagnostic and management strategies for retroperitoneal leiomyosarcoma invading the inferior vena cava: a case report.Discover oncology · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeiomyosarcoma (LMS) is a rare malignancy arising from the smooth muscle, which affects the inferior vena cava (IVC) in 30-40% of cases; the cure relies on complete surgical resection, PATIENTS AND
methodsA 64-year-old woman presented with a 6 cm IVC mass with neoplastic thrombosis and intense PET uptake. Suspecting an IVC LMS, the tumor board recommended up-front surgery.
resultsAn en bloc resection of the tumor and the involved IVC segment II-III with homograft interposition was performed. The procedure involved division of the right gonadal, caudate lobe, lumbar and left adrenal veins; isolation of the IVC and renal veins; followed by cross-clamping and resection under vascular control with hemodynamic stability and no need for veno-venous bypass. Frozen margins on the IVC and renal veins were negative. Blood flow was restored using a cryopreserved cadaveric aortic homograft, trimmed to the appropriate length and implanted end-to-end on the IVC. The right renal vein was anastomosed end-to-side on the graft, while the left renal vein was reconnected using a jump graft crafted from the remaining portion of the cadaveric graft.
conclusionsResection of retroperitoneal leiomyosarcoma requires both oncological and vascular expertise to achieve optimal curative outcomes and restore physiological vascular flow when necessary.
Indexed as
Identifiers
39909990What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.